611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net
Medical Disorders
Basic InformationLookupsLatest News
Live Near a 'Superfund' Site? Your Life Span Might Be ShorterHormone Treatments May Raise Blood Pressure in Transgender PeopleUnexplained Drop in Resting Heart Rate in Youth 'Not a Good Thing'Common MS Meds Might Be Less Effective in Black PatientsIs It Allergies or COVID? Expert Shows How to Tell the DifferenceMany Employees Have Mixed Feelings as Offices ReopenHalf of American Adults Have Now Gotten at Least One COVID Vaccine ShotWarmer Climate, More Pollen, Worse Allergies: How to Fight BackCycling During Dialysis? It Might Help PatientsPregnancy Raises the Risk for Kidney StonesU.S. Marines Study Finds Getting COVID Won't Protect Young People From ReinfectionKnow the Signs of Rare Blood Clot Linked With J & J Vaccine1 in 50 COVID Patients in ICU Will Develop a StrokeBooster Shots a Likely Reality for COVID-Vaccinated AmericansAHA News: The Link Between Structural Racism, High Blood Pressure and Black People's HealthMost Young Americans Eager to Get COVID Vaccine: PollRashes Can Occur After COVID Vaccine,  But Dermatologists Say 'Don't Worry'Even Before COVID, Many More People Died Early in U.S. Versus EuropeCOVID Plus 'Bleeding' Stroke Doubles a Patient's Death RiskLower Rates of COVID in States That Mandated Masks: StudyCDC Panel Says It Needs More Time to Study J&J Vaccine Clotting CasesOne Good Way to Help Beat COVID: ExerciseDiabetes Can Lead to Amputations, But Stem Cell Treatment Offers HopeResearch Shows Links Between Gum Disease and Alzheimer'sNo Rise in Global Suicide Rate in First Months of PandemicCloth Masks Do Make Workouts a Bit Tougher, Study FindsMany Kids Who Develop Severe COVID-Linked Syndrome Have Neurologic SymptomsBiden, Fauci Say Pause in J&J COVID Vaccine Is Sign That Safety Comes FirstAHA News: Straight Answers to Common Questions About COVID-19 VaccinesJ&J Vaccine 'Pause' Is Not Mandate Against the Shot, FDA SaysU.K. Variant Won't Trigger More Severe COVID, Studies FindNewborns Won't Get COVID Through Infected Mom's Breast Milk: StudyU.S. Health Agencies Call for Pause in J&J COVID Vaccine After 6 People Develop ClotsUrinary Incontinence Surgery Won't Raise a Woman's Cancer RiskCOVID Vaccines Trigger Protective Immune Response in Nursing Home Residents: StudyCOVID Vaccines Might Not Protect Certain Cancer PatientsHad Facial Fillers? What You Need to Know About COVID VaccinesAntibody Cocktail May Curb Infection in Unvaccinated Who Are Exposed to COVID-19Scientists Find Clues to Why AstraZeneca's Vaccine May Cause ClotsYou've Got Fungi in Your Lungs, and That's OKNon-Emergency Surgeries Are Rebounding, But Backlogs RemainPandemic Has Put Many Clinical Trials on HoldSupply of J&J COVID Vaccine to Drop 86 Percent Next WeekStressed, Exhausted: Frontline Workers Faced Big Mental Strain in PandemicNIH Starts Trial Looking at Rare Allergic Reactions to COVID VaccinesNot Just Keyboards: Many Types of Workers Can Develop Carpal TunnelBlack Women Are Dying of COVID at Much Higher Rates Than White MenTwo Vaccines Show Effectiveness Against Emerging COVID VariantsWomen More Prone to Concussion's Long-Term Harms: StudyCOVID Cases Climb in the Midwest as British Variant Takes Hold in U.S.
Questions and AnswersLinksBook Reviews
Related Topics

Men's Health
Women's Health

Study Debunks Notion That Statin Meds Trigger Muscle Aches

HealthDay News
by By Amy Norton HealthDay Reporter
Updated: Mar 1st 2021

new article illustration

MONDAY, March 1, 2021 (HealthDay News) -- People taking statin drugs often complain of muscle aches, but a new study finds the medications are unlikely to be the culprit.

The results come from a trial involving patients who had quit taking their statins, or were considering quitting, due to muscle pain.

The researchers found that those aches were just as likely to flare when the patients were given a placebo (inactive pills) rather than an actual statin.

Experts said the findings add to evidence that statin patients' muscle complaints often reflect a "nocebo" effect. That is, people expect to have muscle woes, so they do.

The pain is real, and doctors should not dismiss it, said Dr. Khurram Nasir, chief of cardiovascular prevention and wellness at Houston Methodist Hospital.

But this study, along with other recent research, "leaves little doubt," Nasir said: The muscle symptoms are related to "taking a pill, not to taking a statin."

Nasir, who was not involved in the research, is also a member of the American College of Cardiology's Prevention Section and Leadership Council.

"As doctors, we shouldn't ignore these muscle symptoms," he stressed. "We should engage patients to have a conversation and show them data like these."

Statins help lower LDL ("bad") cholesterol and also appear to have anti-inflammatory effects. The medications, Nasir said, are a "cornerstone" of heart attack and stroke prevention, especially in patients at high risk (due to a past heart attack or stroke, for instance).

For the most part, the drugs are considered safe. But they can, in rare cases, cause a serious muscle disorder called rhabdomyolysis, where muscle fibers break down and release their contents into the blood, which can damage the kidneys.

That's estimated to occur in 0.2 out of every 10,000 statins users annually. A relatively larger number -- one in 10,000 -- get "nasty" muscle symptoms like widespread pain, tenderness and weakness, said Dr. Liam Smeeth, the senior researcher on the new study.

That has raised the question of whether statins also cause less-serious muscle symptoms, according to Smeeth, a professor at the London School of Hygiene and Tropical Medicine, in the United Kingdom.

But muscle aches are also very common, Smeeth said, often with unclear causes.

"Seeking a cause is an understandable response," Smeeth said. "And reading reports or hearing rumors that statins cause pain can easily lead to beliefs."

To put the issue to a scientific test, Smeeth and his colleagues recruited 200 patients who'd recently quit their statins -- or were thinking about quitting -- due to muscle symptoms.

The investigators randomly assigned each patient to six two-month treatment periods, during which they either received atorvastatin (Lipitor) or identical-looking placebo pills.

Overall, the study found, patients were no more likely to report muscle symptoms while taking the statin, versus periods on the placebo. And there was no obvious difference in "intolerable" muscle symptoms: During statin periods, 9% of patients withdrew from the trial due to intolerable symptoms, while 7% withdrew during placebo periods.

After the study's completion, two-thirds of participants said they planned to restart their statin regimen.

"We have convincingly demonstrated that while aches and pains are common, they are not caused by statins," Smeeth said.

In the real world, he added, the decision on whether to start a statin is "clearly a personal choice." But fear over muscle pain should not be a deterrent, Smeeth said.

When statin users do develop muscle pain, Nasir said they should not simply stop the medication. Instead, he advised they talk to their doctor. One option could be to lower the statin dose to see whether the symptoms wane, he said.

The dosage question is one limitation of this study, Nasir noted. Patients were given a 20-milligram dose of atorvastatin, which is a moderate one.

"We can't extrapolate these findings to high-dose regimens," Nasir said. "I think now we need similar trials of high-dose statins."

Given the benefits of statins, Nasir said doctors should work to address any muscle symptoms that could cause patients to abandon the drugs.

"The bottom line is, the symptoms they're feeling are real," he said.

The study, published online Feb. 24 in the BMJ, was funded by the U.K. government.

More information

The American Heart Association has more on cholesterol medications.

SOURCES: Liam Smeeth, MBChB, PhD, MSc, professor, clinical epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom; Khurram Nasir, MD, MPH, chief, cardiovascular prevention and wellness, Houston Methodist Hospital, and member, Prevention Section and Leadership Council, American College of Cardiology, Washington, D.C.; BMJ, Feb. 24, 2021, online